VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Administration of letrozole
Phase 3
Small molecule
I
IVI Madrid
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Controlled Ovarian Stimulation
Recruiting
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Controlled Ovarian Stimulation
Phase 3
Recruiting
Clinical
Trials by Indication
[1]
Controlled Ovarian Stimulation
1 trial
Effects of Letrozole During the Luteal Phase After Controlled Ovarian Stimulation in Oocyte Donors.
Recruiting
·
I
IVI Madrid
·
Phase 3
·
NCT06244745
·
152 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Administration of letrozole. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Administration of letrozole compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Administration of letrozole. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
IVI Madrid company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 3
[1]
Company
I
IVI Madrid
Related News